It is well recognized that blood pressure control is sub-optimal. For example, in the UK, 30% of the adult population are hypertensive, with a blood pressure over 140/90 mm Hg, or on blood pressure lowering medication.1 The 'rule of halves' continues to apply, with over half of hypertensives not on any treatment, and over half of the people who are on treatment having blood pressures over the 140/ 90 mm Hg threshold.1 It is regarded as almost axiomatic that a significant reason that blood pressure remains poorly controlled in people on treatment is their non-adherence with therapy. For example, the World Health Organization estimates that 50-70% of people do not take their antihypertensive medication as prescribed, and describes poor adherence as the 'most important cause of uncontrolled blood pressure'.2 This orthodoxy is challenged by the findings of Schroeder et al.,3 reported in this issue. Schroeder et al. analysed the relationship between adherence over 6 months and achieved blood pressure in patients recruited from primary care who at baseline were on treatment for hypertension, but their blood pressure was over 150/90 mm Hg. Surprisingly, they found no relationship between medication adherence and achieved blood pressure, which suggests that adherence was not an important factor in this general practice population in explaining poor blood pressure control. The other interesting finding from these investigators was that adherence at baseline, measured by the strict method of timing compliancethat is, the percentage of doses taken at the correct time interval -was high, with mean timing compliance at just over 90%.4 Therefore, there are two questions raised by this research that need to be explored: Is adherence to medication in people with hypertension better than had been previously thought? And is it a significant factor in determining poor blood pressure control?
Levels of adherence in hypertensionA systematic review of studies looking at compliance with blood pressure medication found overall mean 'taking compliance' of 94% for a once daily regime, and 88% for a twice daily regime.5 'Taking compliance' is a slightly less strict criterion than timing compliance, as it simply reflects the percentage of prescribed doses taken, without specifying whether the dosing interval was correct. Nevertheless, Schroeder et al.'s results are broadly consistent with the findings of this systematic review. Indeed, a recent study set in primary care in Scotland also found over 90% adherence (defined as the number of days with treatment supply divided by the total number of days from the first prescription to the end of the study period). 6 However, there are difficulties in interpretation of studies measuring adherence. Study populations may not be representative, and the measures and definitions of adherence used vary. Schroeder et al.'s 3 study, in common with many others, was performed in the context of a randomized controlled trial. It is likely that adherence is better in patients who are willing to be recruited t...